Skip to content

Session 7 — Precision immune oncology

Series: 2026 SITC Computational IO Series, session 7 of 10 Date: October 1, 2026, 12:00–1:00 p.m. ET Moderator: Benjamin Vincent, MD — University of North Carolina School of Medicine Faculty: Vinod Balachandran, MD — Memorial Sloan Kettering Cancer Center Recording: SITC OnDemand after delivery Status: Upcoming

What the session covers

Precision immuno-oncology — matching immunotherapy to patients on molecular evidence. Balachandran is a surgeon-scientist working on pancreatic cancer immunology and neoantigen-directed therapy, so the talk is likely to be anchored in a hard-to-treat, low-mutational-burden disease where the precision-IO argument is most contested. Inferred from the speaker's field; confirm after delivery.

Why it matters to this corpus

  • The clinical-translation end of the series. Feeds the SITC 2026 trials/ and tools/ templates, which are explicitly built to hold both the readout and the assay that produced it.
  • Pancreatic-specific overlap with aacr-pancreatic-2026/ — worth cross-linking once the disease focus is confirmed.
  • Neoantigen and vaccine biology connects back to session 5 (immunogen design) and forward to session 9 (TCR–antigen prediction): the same pipeline, at three stages.
  • Vincent also moderates session 3, linking early detection to precision treatment.

Open items

  • [ ] Capture the recording once posted.
  • [ ] Confirm the talk title and whether the content is pancreatic-specific or pan-tumor.
  • [ ] Cross-link to any trial cohorts discussed, in sitc-2026/trials/ or asco-2026/trials/.

Sources